Schneider, Sophie
Ferte, Thomas
Ducharme, Océane
Dousset, Léa
Prey, Sorilla
Dutriaux, Caroline
Gerard, Emilie
Beylot-Barry, Marie
Pham-Ledard, Anne http://orcid.org/0000-0003-2960-6084
Article History
Received: 23 August 2023
Accepted: 22 December 2023
First Online: 16 March 2024
Declarations
:
: Financial interests: Schneider S, Pham-Ledard A, Ferte T, Dousset L, Beylot-Barry M declare they have no financial interests. Dutriaux C, Gérard E, Prey S, has received speaker and consultant honoraria from Bristol-Myers Squibb, Merck Sharps Dohme and Sanofi. Non-financial interests: Dutriaux C, Gérard E has served on advisory boards for Bristol-Myers Squibb, Merck Sharps Dohme and Sanofi.
: Informed consent was obtained from all individual participants included in the study.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Research Ethics Committee of Bordeaux (CER-BDX2023-56).